The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1976) · Medical Entomology and Zoology · Cited by 8,899
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111704 · Cited by 5,157 · cited 1×
“The Columbia-Suicide Severity Rating Scale (C-SSRS) (Posner et al., 2011; Chappell et al., 2012)was used to assess and classify reported suicidal behavior.”
MethodA RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561 · cited 1×
“hyperprolactinemia (and associated sexual effects), sedation, weight gain and other metabolic effects (De Hert et al., 2012; Leucht et al., 2013).”
BackgroundSchizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,170
Salomon, J. A., Vos, T., Hogan, D. R., Gagnon, M., Naghavi, M., Mokdad, A., Begum, N., Shah, R., Karyana, M., Kosen, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61680-8 · Cited by 1,322
Morosini, P. L., Magliano, L., Brambilla, L., Ugolini, S., & Pioli, R. (2000) · PubMed · Cited by 1,168
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
Morosini, P. L., Magliano, L., Brambilla, L., Ugolini, S., & Pioli, R. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101004323.x · Cited by 1,097 · cited 1×
“Additional secondary outcomes were changes from baseline at week 6 in Personal and Social Performance scale (PSP) (Morosini et al., 2000; Gharabawi et al., 2007), PANSS positive and negative subscales (Kay et al.”
BackgroundMarder, S. R., Davis, J. M., & Chouinard, G. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1205 · Cited by 759
Lieberman, J. A., Perkins, D., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 593
VANDERGAAG, M., HOFFMAN, T., REMIJSEN, M., HIJMAN, R., DEHAAN, L., VANMEIJEL, B., VANHARTEN, P., VALMAGGIA, L., DEHERT, M., & CUIJPERS, A. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.03.021 · Cited by 559
Maeda, K., Sugino, H., Akazawa, H., Amada, N., Shimada, J., Futamura, T., Yamashita, H., Ito, N., McQuade, R. D., Mørk, A., et al. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213793 · Cited by 372
Self-citationEpidemiology of Schizophrenia: Review of Findings and Myths
Messias, E. L., Chen, C.-Y., & Eaton, W. W. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.007 · Cited by 310
Correll, C. U. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71701-6 · Cited by 273
Past and Present Progress in the Pharmacologic Treatment of Schizophrenia
Kane, J. M., & Correll, C. U. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06264yel · Cited by 232
Self-citationLeucht, S. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13049su1c.02 · Cited by 174
Quality of life in schizophrenic patients
Bobes, J., Garcia-Portilla, M. P., Bascaran, M. T., Saiz, P. A., & Bouzoño, M. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.2/jbobes · Cited by 169
Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics
Kane, J. M., Fleischhacker, W., Hansen, L. K., Perlis, R. H., Pikalov, A., & Assunção-Talbott, S. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08r04210 · Cited by 154
Self-citationMaeda, K., Lerdrup, L., Sugino, H., Akazawa, H., Amada, N., McQuade, R. D., Stensbøl, T. B., Bundgaard, C., Arnt, J., & Kikuchi, T. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213819 · Cited by 144
Self-citationPsychopathology of Schizophrenia: Initial Validation of a 5-Factor Model
Lindenmayer, J., Bernstein-Hyman, R., Grochowski, S., & Bark, N. M. (2010) · Psychopathology · doi:10.1159/000284896 · Cited by 142
Montoya, A. G., Valladares, A., Lizán, L., San, L., Escobar, R., & Paz, S. (2011) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-9-18 · Cited by 142
Aripiprazole in schizophrenia and schizoaffective disorder: A review
Stip, É., & Tourjman, V. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.01.021 · Cited by 127
Fleischhacker, W. W. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.12.2091 · Cited by 96
Principal components and further possibilities with the PANSS
von Knorring, L., & Lindström, E. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb05937.x · Cited by 64
Latent structures underlying schizophrenic symptoms: a five-dimensional model
Nakaya, M. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00018-3 · Cited by 52
Gharabawi, G. M., Bossie, C. A., Turkoz, I., Kujawa, M. J., Mahmoud, R. A., & Simpson, G. M. (2007) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31815c1982 · Cited by 36
Melkersson, K. I. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.025 · Cited by 36
Initial Validity and Reliability Data on the Columbia–Suicide Severity Rating Scale
Chappell, P. B., Feltner, D. E., Makumi, C. W., & Stewart, M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010123 · Cited by 34
Potkin, S. G., Raoufinia, A., Mallikaarjun, S., Bricmont, P., Peters-Strickland, T. S., Kasper, W., Baker, R. A., Eramo, A., Sanchez, R., & McQuade, R. D. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.821973 · Cited by 32
Self-citationLaoutidis, Z. G., & Kioulos, K. T. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3764-2 · Cited by 30
Cited by
Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia
Leucht, S., Crippa, A., Siafis, S., Patel, M. X., Orsini, N., & Davis, J. M. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19010034 · Cited by 301
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis
Barton, B. B., Segger, F., Fischer, K., Obermeier, M., & Musil, R. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1713091 · Cited by 216
Ward, K., & Citrome, L. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s169369 · Cited by 181
“…on previous research efforts by enrolling patients from up to three prior phase III studies, including the aforementioned investigation by Fleischhacker et al 8 and two 6-week acute efficacy trials, 4,5 in addition to patients who had never previously participated in a brexpiprazole study.”
Citrome, L. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12752 · Cited by 107
Fleischhacker, W. W., Hobart, M., Ouyang, J., Forbes, A., Pfister, S., McQuade, R. D., Carson, W. H., Sanchez, R., Nyilas, M., & Weiller, E. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw076 · Cited by 88
Self-citation
Metadata
- Authors
- Kane, J. M., Skuban, A., Ouyang, J., Hobart, M., Pfister, S., McQuade, R. D., Nyilas, M., Carson, W. H., Sanchez, R., & Eriksson, H.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 164
- Issue
- 1-3
- Pages
- 127-135
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W1990121386
- Cited by
- 325
- References
- 34
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.